Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states

European Journal of Neuroscience

Volumn 27, Issue 7, 2008, Pages 1615-1625

  Klein, Ronald L ^a   Dayton, Robert D ^a   Tatom, Jason B ^a   Diaczynsky, Cynthia G ^a   Salvatore, Michael F ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Adeno associated virus; Gene transfer; Neurodegenerative diseases; Progressive supranuclear palsy; Rats

Indexed keywords

DOPAMINE; OXIDOPAMINE; PARVOVIRUS VECTOR; TAU PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; IMMUNOCOMPETENT CELL; MALE; NERVE CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTYPE; WESTERN BLOTTING;

ANIMALS; CELL LINE; DEPENDOVIRUS; DOPAMINE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; MALE; NEURODEGENERATIVE DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SEROTYPING; TAU PROTEINS; TAUOPATHIES;

EID: 41549129361     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2008.06161.x     Document Type: Article

References (42)

1. Cairns, N.J., Bigio, E.H., Mackenzie, I.R., Neumann, M., Lee, V.M., Hatanpaa, K.J., White, C.L., Schneider, J.A., Grinberg, L.T., Halliday, G., Duyckaerts, C., Lowe, J.S., Holm, I.E., Tolnay, M., Okamoto, K., Yokoo, H., Murayama, S., Woulfe, J., Munoz, D.G., Dickson, D.W., Ince, P.G., Trojanowski, J.Q. Mann, D.M. (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. (Berl.), 114, 5 22.
2. Carman, L.S., Gage, F.H. Shults, C.W. (1991) Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res., 553, 275 283.
3. Cearley, C.N. Wolfe, J.H. (2006) Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9 & rh10 in the mouse brain. Mol. Ther., 13, 528 537.
4. Dickson, D.W. (1999) Tau and synuclein and their role in neuropathology. Brain Pathol., 9, 657 661.
5. Di Maria, E., Tabaton, M., Vigo, T., Abbruzzese, G., Bellone, E., Donati, C., Frasson, E., Marchese, R., Montagna, P., Munoz, D.G., Pramstaller, P.P., Zanusso, G., Ajmar, F. Mandich, P. (2000) Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann. Neurol., 47, 374 377.
6. Friedmann, T. (2007) A new serious adverse event in a gene therapy study. Mol. Ther., 15, 1899 1900.
7. Fukuchi, K., Tahara, K., Kim, H.D., Maxwell, J.A., Lewis, T.L., Accavitti-Loper, M.A., Kim, H., Ponnazhagan, S. Lalonde, R. (2006) Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease. Neurobiol. Dis., 23, 502 511.
8. Furler, S., Paterna, J.C., Weibel, M. Bueler, H. (2001) Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons. Gene Ther., 8, 864 873.
9. Gong, Y., Meyer, E.M., Meyers, C.A., Klein, R.L., King, M.A. Hughes, J.A. (2006) Memory related deficits following selective hippocampal expression of Swedish mutation amyloid precursor protein in the rat. Exp. Neurol., 200, 371 377.
10. Gorbatyuk, O., Shoudong, L., Sullivan, L.F., Chen, W., Kondrikova, G., Manfredsson, F.P., Mandel, R.J. Muzyczka, N. (2008) The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc. Natl Acad. Sci. U.S.A., 105, 763 768.
11. Hara, H., Monsonego, A., Yuasa, K., Adachi, K., Xiao, X., Takeda, S., Takahashi, K., Weiner, H.L. Tabira, T. (2004) Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. J. Alz. Dis., 6, 483 488.
12. Hefti, F., Melamed, E. Wurtman, R.J. (1980) Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res., 195, 123 137.
13. Hefti, F., Enz, A. Melamed, E. (1985) Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs. Neuropharmacology, 24, 19 23.
14. Hudson, J.L., van Horne, C.G., Stromberg, I., Brock, S., Clayton, J., Masserano, J., Hoffer, B.J. Gerhardt, G.A. (1993) Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res., 626, 167 174.
15. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R.C., Stevens, M., de Graaff, E., Wauters, E., van Baren, J., Hillebrand, M., Joosse, M., Kwon, J.M., Nowotny, P., Che, L.K., Norton, J., Morris, J.C., Reed, L.A., Trojanowski, J., Basun, H., Lannfelt, L., Neystat, M., Fahn, S., Dark, F., Tannenberg, T., Dodd, P.R., Hayward, N., Kwok, J.B., Schofield, P.R., Andreadis, A., Snowden, J., Craufurd, D., Neary, D., Owen, F., Oostra, B.A., Hardy, J., Goate, A., van Swieten, J., Mann, D., Lynch, T. Heutink, P. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393, 702 705.
16. Ishizawa, K., Lin, W.L., Tiseo, P., Honer, W.G., Davies, P. Dickson, D.W. (2000) A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol., 59, 513 524.
17. Iwata, N., Mizukami, H., Shirotani, K., Takaki, Y., Muramatsu, S., Lu, B., Gerard, N.P., Gerard, C., Ozawa, K. Saido, T.C. (2004) Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain. J. Neurosci., 24, 991 998.
18. Kaplitt, M.G., Feigin, A., Tang, C., Fitzsimons, H.L., Mattis, P., Lawlor, P.A., Bland, R.J., Young, D., Strybing, K., Eidelberg, D. During, M.J. (2007) Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease. and open label, phase I trial. Lancet, 369, 2097 2105.
19. King, M.A., Scotty, N., Klein, R.L. Meyer, E.M. (2002) Particle detection, number estimation, and feature measurement in gene transfer studies: optical fractionator stereology integrated with digital image processing and analysis. Methods, 28, 293 299.
20. Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T.E., Muzyczka, N., Mandel, R.J. Bjorklund, A. (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J. Neurosci., 22, 2780 2791.
21. Klein, R.L., King, M.A., Hamby, M.E. Meyer, E.M. (2002) Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum. Gene Ther., 13, 605 612.
22. Klein, R.L., Lin, W.L., Dickson, D.W., Lewis, J., Hutton, M., Duff, K., Meyer, E.M. King, M.A. (2004) Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau. Am. J. Pathol., 164, 347 353.
23. Klein, R.L., Dayton, R.D., Lin, W.L. Dickson, D.W. (2005) Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat. Neurobiol. Dis., 20, 64 73.
24. Klein, R.L., Dayton, R.D., Leidenheimer, N.J., Jansen, K., Golde, T.E. Zweig, R.M. (2006) Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol. Ther., 13, 517 527.
25. Klein, R.L., Dayton, R.D., Tatom, J.B., Henderson, K.M. Henning, P.P. (2008) AAV 8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol. Ther., 16, 89 96.
26. Kumar-Singh, S. Van Broekhoven, C. (2007) Frontotemporal lobar degeneration: Current concepts in light of recent advances. Brain Pathol., 17, 104 113.
27. Lee, C.S., Sauer, H. Björklund, A. (1996) Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience, 72, 641 653.
28. Lee, V.M., Kenyon, T.K. Trojanowski, J.Q. (2005) Transgenic animal models of tauopathies. Biochim. Biophys. Acta, 1739, 251 259.
29. Levites, Y., Jansen, K., Smithson, L.A., Dakin, R., Holloway, V.M., Das, P. Golde, T.E. (2006) Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta40 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. J. Neurosci., 26, 11 923 11 928.
30. Mirra, S.S., Murrell, J.R., Gearing, M., Spillantini, M.G., Goedert, M., Crowther, R.A., Levey, A.I., Jones, R., Green, J., Shoffner, J.M., Wainer, B.H., Schmidt, M.L., Trojanowski, J.Q. Ghetti, B. (1999) Tau pathology in a family with dementia and a P301L mutation in tau. J. Neuropathol. Exp. Neurol., 58, 335 345.
31. Oertel, W.H., Tappaz, M.L., Berod, A. Mugnaini, E. (1982) Two-color immunohistochemistry for dopamine and GABA neurons in rat substantia nigra and zona incerta. Brain Res. Bull., 9, 463 474.
32. Parkinson Study Group PRECEPT Investigators (2007) Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology, 69, 1480 1490.
33. Paxinos, G. Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates, 4th Edn. Academic Press, San Diego.
34. Poorkaj, P., Muma, N.A., Zhukareva, V., Cochran, E.J., Shannon, K.M., Hurtig, H., Koller, W.C., Bird, T.D., Trojanowski, J.Q., Lee, V.M. Schellenberg, G.D. (2002) An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann. Neurol., 52, 511 516.
35. Schneider, J.A., Bienias, J.L., Gilley, D.W., Kvarnberg, D.E., Mufson, E.J. Bennett, D.A. (2002) Improved detection of substantia nigra pathology in Alzheimer's disease. J. Histochem. Cytochem., 50, 99 106.
36. Senut, M.C., Suhr, S.T., Kaspar, B. Gage, F.H. (2000) Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain. J. Neurosci., 20, 219 229.
37. Sondhi, D., Hackett, N.R., Peterson, D.A., Stratton, J., Baad, M., Travis, K.M., Wilson, J.M. Crystal, R.G. (2007) Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 Rhesus Macaque-derived adeno-associated virus vector. Mol. Ther., 15, 481 491.
38. St Martin, J.L., Klucken, J., Outeiro, T.F., Nguyen, P., Keller-McGandy, C., Cantuti-Castelvetri, I., Grammatopoulos, T.N., Standaert, D.G., Hyman, B.T. McLean, P.J. (2007) Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J. Neurochem., 100, 1449 1457.
39. Wakabayashi, K., Oyanagi, K., Makifuchi, T., Ikuta, F., Homma, A., Homma, Y., Horikawa, Y. Tokiguchi, S. (1994) Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol., 87, 545 553.
40. Yamada, M., Iwatsubo, T., Mizuno, Y. Mochizuki, H. (2004) Overexpression of alpha synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alph-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. J. Neurochem., 91, 451 461.
41. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.M., Iwata, N., Saido, T.C., Maeda, J., Suhara, T., Trojanowski, T.Q. Lee, V.M. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron, 53, 337 351.
42. Zhang, J., Wu, X., Qin, C., Qi, J., Ma, S., Zhang, H., Kong, Q., Chen, D., Ba, D. He, W. (2003) A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease. Neurobiol. Dis., 14, 365 379.